Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Organ Transplantation, Renal Transplantation

Interventions

DRUG

Everolimus (Certican)

DRUG

Cyclosporine (Neoral)

DRUG

Steroid

Each patient was administered i.v. prednisone (or equivalent) pre- or intra-operatively according to center practice.

DRUG

Basiliximab (Simulect)